Bed Bath & Beyond Inc.,
- ExchangeNASDAQ Stock Market
- SectorGeneral Retailers
- CountryUnited States
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
La tendance de fond est clairement orientée à la baisse. Le MACD est négatif, il confirme cette tendance. La reprise est une consolidation qui va buter sur 16,400 $ prochainement. Le prochain objectif est à 13,488 $, puis 10,458 $. Le franchissement de 19,400 $ remettrait en cause la suite de la baisse.
The background trend is clearly bearish. The negative MACD confirms the trend. The rise is a consolidation that will soon bump against the level at $16.400. The next target is at $13.488, then $10.458. Passing $19.400 would question the continuation of the fall.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Bed Bath& Beyond Inc.. Global Credit Research- 20 Apr 2020. New York, April 20, 2020-- Moody's Investors Service has completed a periodic review of the ratings of Bed Bath& Beyond Inc. and other ratings that are associated with the same analytical unit.
Rating Action: Moody's changes Bed Bath's outlook to negative; affirms Ba2 CFR. Global Credit Research- 03 Apr 2020. New York, April 03, 2020-- Moody's Investors Service, affirmed Bed Bath& Beyond Inc.' s Ba2 corporate family rating, its Ba2-PD probability of default rating and its Ba2 senior unsecured notes rating.
BED BATH & BEYOND INCO. (US), a company active in the Specialty Retailers industry, improves its market behaviour and slightly increases its general evaluation. The independent financial analyst theScreener just upgraded the stock market behaviour as moderately risky. At a fundamental level, theScreener confirms 1 out of 4 possible stars; the general evaluation is slightly increased to Neutral but the title remains under pressure. As of the analysis date March 6, 2020, the closing price was USD 9.79 and its target price was estimated at USD 8.43.